Sort
50,496 grants matching “lung cancer”
Laboratory and Clinical studies on T-cells recognizing NSCLC
$384,815James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Understanding the role of κB-Ras proteins in tumorigenesis
$384,782Sankar Ghosh · Columbia University Health Sciences · R01 · FY2018 · CA
Understanding the role of κB-Ras proteins in tumorigenesis
$384,782Sankar Ghosh · Columbia University Health Sciences · R01 · FY2017 · CA
Understanding the role of κB-Ras proteins in tumorigenesis
$384,782Sankar Ghosh · Columbia University Health Sciences · R01 · FY2016 · CA
Understanding the role of κB-Ras proteins in tumorigenesis
$384,782Sankar Ghosh · Columbia University Health Sciences · R01 · FY2020 · CA
Regulation of non-proteolytic ubiquitination in cancer chemoresistance and progression
$384,758Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway
$384,758Nadya M Dimitrova · Yale University · R37 · FY2022 · CA
Endogenous Regulators of Inflammation in Periodontal Tissue Homeostasis
$384,750Sinem Esra Sahingur · University Of Pennsylvania · R01 · FY2020 · DE
Inference in Regression Models with Missing Covariates
$384,746Joseph G Ibrahim · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA
MicroRNA Therapeutics in Non-small Cell Lung Cancer
$384,723Frank J. Slack · Yale University · P50 · FY2017 · CA
Development of BIO 300 for mitigation and/or treatment of radiation pneumonitis and fibrosis
$384,716Isabel Lauren Jackson · University Of Maryland Baltimore · U19 · FY2023 · AI
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
$384,644Guangwen Ren · Jackson Laboratory · R37 · FY2024 · CA
Drivers of histologic transformation in EGFR-mutant lung cancer
$384,644Helena Yu · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Defining the impact of mutant oncogene zygosity
$384,644Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Predicting sensitivity and resistance in RET-driven cancers
$384,644Alexander Drilon · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis
$384,627Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Structure-Based Design of Xe-129 NMR Biosensors for Multiplexed Cancer Detection
$384,595Ivan Julian Dmochowski · University Of Pennsylvania · R01 · FY2015 · GM
Regulation of human IL12/IL23 responsiveness by IL12RB1
$384,584Richard Robinson · Medical College Of Wisconsin · R01 · FY2016 · AI
Vaccine and radiation for the therapy of human cancers
$384,564James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Molecular mechanisms of lung disease in ataxia telangiectasia
$384,546Joann M Sekiguchi · University Of Michigan At Ann Arbor · R01 · FY2011 · HL
Unmet needs for specific subsets of EGFR mutated lung cancer
$384,536Daniel Botelho Costa · Beth Israel Deaconess Medical Center · R37 · FY2024 · CA
The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis
$384,502Michael Birrer · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs
$384,496Benjamin Andrew Toll · Medical University Of South Carolina · R01 · FY2022 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$384,475John Tisdale · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Dissecting and Targeting RB1-Mutant Osteosarcoma
$384,471Dung-Fang Lee · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA